NASDAQ:CGTX

Cognition Therapeutics Stock Predictions

etoro logo Buy CGTX
*Your capital is at risk
$1.42
+0.0700 (+5.19%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CGTX Prediction Chart

CGTX Predictions History

Latest community submissions for CGTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Aug 28, 2025 $2.97 -2.81% $2.48 V 80.08% 1
Aug 28, 2025 Bullish $2.48 X 0
Aug 28, 2025 Bullish $2.48 X 0
Aug 27, 2025 Bearish $3.06 X 0
Aug 27, 2025 $2.72 -4.85% $3.06 X 88.77% 0
Aug 27, 2025 $2.77 -3.03% $3.06 X 90.47% 0
Aug 27, 2025 Bearish $3.06 X 0
Aug 26, 2025 $3.05 -4.05% $2.86 V 93.13% 1
Aug 26, 2025 $3.10 -2.53% $2.86 V 91.44% 1
Aug 26, 2025 Bullish $2.86 V 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CGTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT COGNITION THERAPEUTICS, INC.
Cognition Therapeutics
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinica...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE